A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2021.04.03.21254823: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Study participants: All the individuals who received vaccines, in the above-mentioned centres, and who provided consent to participate were enrolled in the study.
IRB: Ethical permission: The study started after obtaining permission from the Ethics Committee of the Institute of Medical Sciences, Banaras Hindu University, and written informed consent was taken from all the participants. 2.6.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Each mL of the dose administered contains 5 × … SciScore for 10.1101/2021.04.03.21254823: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Study participants: All the individuals who received vaccines, in the above-mentioned centres, and who provided consent to participate were enrolled in the study.
IRB: Ethical permission: The study started after obtaining permission from the Ethics Committee of the Institute of Medical Sciences, Banaras Hindu University, and written informed consent was taken from all the participants. 2.6.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Each mL of the dose administered contains 5 × 1010 simian adeno-viral particles produced in genetically modified human embryonic kidney (HEK) 293 cells. HEKsuggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
